Barinthus Biotherapeutics plc (BRNS) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 14.97M | 0 | 0 | 0 | 0 | 334K | 468K | 6.46M | 6.17M | 17.06M | 15.02M | -1K | 19K | 35K |
| Revenue Growth % | - | - | -100% | - | - | - | - | -100% | -100% | -100% | -100% | -98.04% | -96.88% | 645800% | 32347.37% | 48651.43% | 6885.12% | -100.28% | - | - |
| Cost of Goods Sold | 0 | 907.69K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.44M | 12.19M | 9.74M | 9.72M | 10.36M | 6.88M | 4.37M | 4.51M |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | 2017.74% | 188.71% | 158.05% | 56.97% | 68.99% | -688100% | 23005.26% | 12882.86% |
| Gross Profit | 0 | -907.69K | 0 | 0 | 0 | 0 | 14.97M | 0 | 0 | 0 | 0 | 334K | -8.97M | -5.73M | -3.58M | 7.34M | 4.66M | -6.88M | -4.35M | -4.47M |
| Gross Margin % | - | - | - | - | - | - | 100% | - | - | - | - | 100% | -1917.74% | -88.71% | -58.05% | 43.03% | 31.01% | 688200% | -22905.26% | -12782.86% |
| Gross Profit Growth % | - | - | -100% | - | - | - | - | -100% | 100% | 100% | 100% | -95.45% | -292.72% | 16.77% | 17.76% | 264.13% | 207.01% | -211.12% | - | - |
| Operating Expenses | 6.12M | 11.56M | 15.07M | 23.32M | 20.6M | 23.39M | 24.35M | 18.29M | 16.91M | 19.99M | 16.11M | 26.67M | 12.51M | 19.36M | -10.81M | -5.89M | 4M | 9.79M | 1.18M | 12.37M |
| OpEx % of Revenue | - | - | - | - | - | - | 162.66% | - | - | - | - | 7985.33% | 2672.86% | 299.91% | -175.43% | -34.53% | 26.65% | -978600% | 6231.58% | 35345.71% |
| Selling, General & Admin | 2.53M | 7.64M | 5.17M | 15.38M | 12.64M | 3.06M | 13.42M | 7.2M | 5.99M | 13.62M | 961K | 13.13M | 12.51M | 20.38M | 11.13M | 6.52M | 4M | 9.79M | 1.18M | 12.37M |
| SG&A % of Revenue | - | - | - | - | - | - | 89.65% | - | - | - | - | 3930.54% | 2672.86% | 315.64% | 180.57% | 38.2% | 26.65% | -978600% | 6231.58% | 35345.71% |
| Research & Development | 3.59M | 3.93M | 5.15M | 6.61M | 7.99M | 6.22M | 10.53M | 10.97M | 10.53M | 5.83M | 13.94M | 12.98M | 10.61M | 12.98M | 10.54M | 10.52M | 11.5M | 7.08M | 4.37M | 4.51M |
| R&D % of Revenue | - | - | - | - | - | - | 70.35% | - | - | - | - | 3887.43% | 2267.95% | 201.1% | 171.03% | 61.65% | 76.58% | -708100% | 23005.26% | 12882.86% |
| Other Operating Expenses | 0 | -8K | 1000K | 1000K | -27K | 1000K | 398K | 116K | 389K | 540K | 1000K | 559K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K |
| Operating Income | -6.08M | 4.8M | -15.07M | -23.32M | -20.6M | -23.39M | -9.38M | -18.29M | -16.91M | -19.99M | -16.11M | -26.34M | -21.48M | -25.09M | 7.24M | 13.23M | 654K | -16.67M | -5.54M | -16.84M |
| Operating Margin % | - | - | - | - | - | - | -62.66% | - | - | - | - | -7885.33% | -4590.6% | -388.62% | 117.37% | 77.57% | 4.35% | 1666800% | -29136.84% | -48128.57% |
| Operating Income Growth % | 70.51% | 120.5% | -60.62% | -27.55% | -21.79% | -17.02% | 41.76% | 30.57% | 21.27% | 20.34% | -322.57% | -299% | -3385.02% | -50.55% | 230.71% | 178.57% | 110.6% | -73.03% | - | - |
| EBITDA | -6.08M | 5.7M | -13.87M | -21.32M | -18.57M | -21.96M | -7.91M | -16.82M | -15.48M | -18.55M | -14.63M | -25.04M | -21.06M | -24.72M | 7.62M | 13.43M | 820K | -16.55M | -5.45M | -16.74M |
| EBITDA Margin % | - | - | - | - | - | - | -52.81% | - | - | - | - | -7496.41% | -4500.64% | -382.78% | 123.67% | 78.69% | 5.46% | 1654700% | -28689.47% | -47831.43% |
| EBITDA Growth % | 67.28% | 125.97% | -75.4% | -26.78% | -19.9% | -18.37% | 45.97% | 32.83% | 26.49% | 24.94% | -291.91% | -286.47% | -2668.66% | -49.37% | 239.86% | 180.2% | 113.49% | -72.78% | - | - |
| D&A (Non-Cash Add-back) | 0 | 907.69K | 1.2M | 2M | 2.03M | 1.43M | 1.48M | 1.47M | 1.43M | 1.44M | 1.47M | 1.3M | 421K | 377K | 388K | 192K | 166K | 121K | 85K | 104K |
| EBIT | 0 | -9.41M | -14.63M | -21.14M | -19.67M | -20.58M | -8.12M | -16.94M | -15.54M | -18.1M | -14.71M | -24.95M | -20.33M | -26.02M | 6.83M | 14.69M | 1.7M | -15.46M | -4.58M | -15.97M |
| Net Interest Income | 0 | 392.43K | 459K | 511K | 543K | 625K | 614K | 623K | 763K | 564K | 189K | 508K | 1.59M | 1.3M | 1.03M | 662K | 9K | -18K | 0 | 0 |
| Interest Income | 350K | 406K | 472K | 523K | 556K | 637K | 631K | 635K | 775K | 571K | 196K | 522K | 1.59M | 1.32M | 1.03M | 669K | 83K | 0 | 0 | 0 |
| Interest Expense | -13K | 12.98K | 13K | 12K | 13K | 12K | 17K | 12K | 12K | 7K | 7K | 14K | 0 | 22.16K | 0 | 7K | 74K | 18K | 0 | 0 |
| Other Income/Expense | 525K | -18.12M | 424K | 2.17M | 920K | 2.8M | 1.25M | 1.34M | 1.36M | 1.88M | 1.39M | 1.38M | 3.78M | 5.95M | 1.66M | 3.37M | 2.78M | 1.53M | 973K | 872K |
| Pretax Income | -5.55M | -13.32M | -14.64M | -21.15M | -19.68M | -20.59M | -8.13M | -16.95M | -15.56M | -18.11M | -14.71M | -24.96M | -17.71M | -19.14M | 8.89M | 16.6M | 3.44M | -15.14M | -4.56M | -15.97M |
| Pretax Margin % | - | - | - | - | - | - | -54.33% | - | - | - | - | -7473.05% | -3783.55% | -296.48% | 144.28% | 97.31% | 22.89% | 1513900% | -24015.79% | -45637.14% |
| Income Tax | -19K | -87K | -71K | -25K | -22K | 3K | -3K | -7K | -37K | -820K | -603K | -1.14M | 516K | 2.02M | 674K | 915K | 863K | 32K | 7K | 12K |
| Effective Tax Rate % | 0.34% | 0.65% | 0.48% | 0.12% | 0.11% | -0.01% | 0.04% | 0.04% | 0.24% | 4.53% | 4.1% | 4.55% | -2.91% | -10.55% | 7.58% | 5.51% | 25.11% | -0.21% | -0.15% | -0.08% |
| Net Income | -5.53M | -11.09M | -14.57M | -21.12M | -19.65M | -20.54M | -8.11M | -16.93M | -15.49M | -17.29M | -14.07M | -23.8M | -18.18M | -21.19M | 8.24M | 15.69M | 2.6M | -15.11M | -4.56M | -15.93M |
| Net Margin % | - | - | - | - | - | - | -54.21% | - | - | - | - | -7126.35% | -3884.62% | -328.16% | 133.69% | 91.97% | 17.29% | 1511300% | -23984.21% | -45505.71% |
| Net Income Growth % | 71.85% | 46.01% | -79.52% | -24.77% | -26.85% | -18.78% | 42.34% | 28.87% | 14.8% | 18.39% | -270.74% | -251.67% | -800.31% | -40.2% | 280.86% | 198.53% | 117% | -44.55% | - | - |
| Net Income (Continuing) | -5.53M | -11.07M | -14.57M | -21.13M | -19.66M | -20.59M | -8.13M | -16.94M | -15.52M | -17.29M | -14.11M | -23.82M | -18.22M | -21.16M | 8.22M | 15.69M | 2.57M | -15.17M | -4.57M | -15.98M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 79K | 84K | 96K | 104K | 99K | 106K | 167K | 172K | 183K | 211K | 205K | 253K | 268K | 305K | 315K | 366K | 400K | 437K | 493K | 518K |
| EPS (Diluted) | -0.14 | -0.27 | -0.36 | -0.52 | -0.49 | -0.51 | -0.21 | -0.43 | -0.40 | -0.45 | -0.37 | -0.62 | -0.48 | -0.56 | 0.22 | 0.41 | 0.07 | 0.00 | -0.13 | -0.64 |
| EPS Growth % | 71.43% | 47.06% | -71.43% | -20.93% | -22.5% | -13.33% | 43.24% | 30.65% | 16.67% | 19.64% | -268.18% | -251.22% | -809.01% | - | 269.23% | 164.06% | 103.56% | 100% | - | - |
| EPS (Basic) | -0.14 | -0.27 | -0.36 | -0.52 | -0.49 | -0.51 | -0.21 | -0.43 | -0.40 | -0.45 | -0.37 | -0.62 | -0.48 | -0.56 | 0.22 | 0.42 | 0.07 | 0.00 | -0.13 | -0.64 |
| Diluted Shares Outstanding | 40.85M | 40.53M | 40.66M | 40.34M | 40.27M | 39.35M | 39.42M | 39.04M | 38.77M | 38.6M | 38.53M | 38.41M | 38.01M | 37.68M | 38.16M | 38.17M | 38.35M | 37.19M | 34.84M | 24.9M |
| Basic Shares Outstanding | 40.85M | 40.53M | 40.66M | 40.34M | 40.27M | 39.35M | 39.42M | 39.04M | 38.77M | 38.6M | 38.53M | 38.41M | 38.01M | 37.68M | 37.25M | 37.2M | 37.19M | 37.19M | 34.84M | 24.9M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |